London Osteoporosis Clinic has negotiated discounts for the benefit of visitors to our website
Medichecks offer some 700 tests. Whether you want to feel better, live longer, exercise harder or know yourself inside and out we want to empower you to take control of your health with our easy-to-use tests you can do at home.
The code for LOC is: DRTAHER10 – this will give you 10% off of the prevailing prices at Medichecks.
A wide variety of nutritional “bone health supplements” are available in health-food stores, pharmacies and online. The clinical value of such products can be discussed at appointments with our clinician/nutritionists.
Biocare are Professional Supplement specialists with almost 30 years expertise in developing effective and high-quality nutritional supplements. They offer the following Bone and Joint health products at 15% discount to LOC patients (please register using code P6629).
Solgar has been producing supplements since 1947 with wish to prevent diseases with vitamins and minerals. Since then, they have become one of the most trusted brand in health and wellness, providing solutions for all life stages. By ordering your solgar products you may be eligible for upto 30% discount of the recommended retail prices.
Please contact the office with your orders.
Vitamin D is essential for calcium utilisation of calcium and slows bone density loss, decreasing the risk of fracture.
Calcium halts progression of osteoporosis.
Magnesium supports calcium metabolism.
Boron reduces excretion of calcium, magnesium and vitamin D and increases oestrogen.
Chromium picolinate reduces urinary calcium excretion.
Fish oil increases calcium absorption and helps form new bone by balancing prostaglandins.
Phyto-oestrogens in red clover, sage and celery seed positively affect bone health.
Pantothenic acid and licorice support adrenal hormones.
Vitamin K is required to synthesise osteocalcin a non-collagenous protein found in bone that is released from osteoblasts to reduce bone loss in osteoporosis.
1 WHO, 1994. Osteoporosis Clinical guidelines for prevention and treatment. RCP July 2000
2 Raisz L (2005). “Pathogenesis of osteoporosis: concepts, conflicts, and prospects”. J Clin Invest 115 (12): 3318–25
3 Vestergaard P. Skeletal effects of systemic and topical corticosteroids. Curr Drug Saf 2008 Sep; 3(3):190-3
4 Chiodini I and Scillitani A. Role of Cortisol hypersecretion in the pathogenesis of osteoporosis. Recenti Prog Med 2008 June; 99(6):303-19
5 Greendale GA, Judd HL. The menopause: health implications and clinical management. J Am Geriatr Soc. 1993;41:426-436
6 Bouillon R: Diabetic bone disease. Calcif Tissue Int 49:155–160, 1991
7 McLean RR et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-49.
8 Fraser et al. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study Osteoporosis International 2013; 24( 4): 1161-1168
9 Raisz L (2005). “Pathogenesis of osteoporosis: concepts, conflicts, and prospects”. J Clin Invest 115 (12): 3318–25
10 Reid IR, Ames RW, Evans MC, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995;98:331–5.
11 Elisaf M, Milionis H, Siamopoulos K. Hypomagnesemic hypokalemia and hypocalcemia: Clinical and laboratory characteristics. Mineral Electrolyte Metab 1997;23:105-12.
12 Nielson FH, Hunt CD, Mullen LM, Hunt JR. Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women. FASEB J 1987;1:394–7.
13 Devirian, T. A. and Volpe, S. L. “The Physiological Effects of Dietary Boron.” Crit Rev Food Sci Nutr, 2003;43(2):219-
14 Mc Carthy. Anabolic effects of insulin on bone suggests a role for chromium picolinate in preservation of bone density. Med Hypothesis 1995 45:241-246
15 Van Papendorp DH, Coetzer H, Kruger MC. Biochemical profile of osteoporotic patients on essential fatty acid supplementation. Nutr Res 1995;15:325–34.
16 Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79 (3):362-371.
17 Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr. 2003;77(2): 504-511
18 Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000;15:515–21.
19 Boniface R, Robert AM. Effect of anthocyanins on human connective tissue metabolism in the human. Klin Monbl Augenheilkd. 1996 Dec;209(6):368-72.
20 Mantle D, Wilkins RM, Preedy V. A novel therapeutic strategy for Ehlers-Danlos syndrome based on nutritional supplements. Med Hypotheses. 2005;64(2):279-83.
21 Mazariegos-Ramos E et al, “Consumption of soft drinks with phosphoric acid as a risk factor for the development of hypocalcemia in children. A case control study”, Journal of Pediatrics 1995 126:940-942
22 Rizzoli R and Bonjour J-P. Dietary protein and bone health. J Bone Miner Res 2004; 19:527-31.